Blockchain Nation Switzerland Initiative Launched with Support from Innosuisse and Swiss Innovation Agency
The
NTN Innovation Booster, called the
Blockchain Nation Switzerland program, which is a 4-year initiative that has been co-funded by the
Swiss Innovation Agency and Innosuisse.
The Blockchain Nation initiative will be focused on promoting and supporting blockchain or distributed ledger tech (DLT)-related business. The program will operate systematically and sustainably in order to help local entities adopt blockchain-powered solutions.
Blockchain Nation should provide an opportunity to launch startups and it may create many new jobs as well.
One of the primary goals of this initiative is to connect larger companies and blockchain firms with startups and research teams so they can develop prototypes and innovative business models.
Switzerland s energy transition - Sonnenseite - Ökologische Kommunikation mit Franz Alt sonnenseite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sonnenseite.com Daily Mail and Mail on Sunday newspapers.
Can Switzerland, as planned, cut its CO
2 emissions to zero by 2050? In a study, researchers at the Paul Scherrer Institute PSI have investigated what measures would be necessary to achieve this reduction and how much it might cost per person.
Evangelos Panos is convinced that if Switzerland wants to achieve the zero-emissions target by 2050, it need great efforts.
(Photo: Paul Scherrer Institute/Mahir Dzambegovic)
Study authors Evangelos Panos (left) and Tom Kober know: Electromobility will play an important role in the energy transition.
(Photo: Paul Scherrer Institute/Mahir Dzambegovic)
In August 2019, the Swiss Federal Council decided on an ambitious target to limit climate change: From the year 2050 onward Switzerland should, on balance, discharge no further greenhouse gas emissions. With this commitment, Switzerland meets the internationally agreed goal of limiting global warming to a maximum of 1.5° C compared to the pre-industrial era.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ORION BIOTECHNOLOGY PROJECT AWARDED GRANT TO ADVANCE DRUG DISCOVERY
Orion Biotechnology Canada Ltd.January 14, 2021 GMT
Genève SWITZERLAND, Jan. 14, 2021 (GLOBE NEWSWIRE) Orion Biotechnology Holding SA., a biotechnology company focused on precision engineering small protein therapeutics, today announced that its drug discovery project was awarded funding of CHF 0.9M from Innosuisse, the Swiss Innovation Agency. The project will allow Orion, in collaboration with the University of Geneva, to further expand and optimize drug discovery capabilities using its novel platform. The proprietary platform driven by Dr. Oliver Hartley and his team at the University of Geneva delivers a novel approach to G Protein-Coupled Receptor (GPCR) targeting by precision-engineering natural peptide and protein analogs that bind to GPCR targets with both enhanced potency and tailored signaling activity. The